Stock Market & Financial News
Why Lam Research (LRCX) Dipped More Than Broader Market Today
Lam Research (LRCX) closed at $160.52 in the latest trading session, marking a -4.85% move from the prior day.
Why the Market Dipped But Progressive (PGR) Gained Today
In the latest trading session, Progressive (PGR) closed at $234.85, marking a +1.91% move from the previous day.
Powell Industries (POWL) Suffers a Larger Drop Than the General Market: Key Insights
In the latest trading session, Powell Industries (POWL) closed at $337.07, marking a -7.08% move from the previous day.
Qualcomm (QCOM) Registers a Bigger Fall Than the Market: Important Facts to Note
In the most recent trading session, Qualcomm (QCOM) closed at $178.29, indicating a -1.64% shift from the previous trading day.
Why Palantir Technologies Inc. (PLTR) Dipped More Than Broader Market Today
Palantir Technologies Inc. (PLTR) concluded the recent trading session at $183.57, signifying a -2.12% move from its prior day's close.
Roblox (RBLX) Sees a More Significant Dip Than Broader Market: Some Facts to Know
Roblox (RBLX) closed at $88.51 in the latest trading session, marking a -6.18% move from the prior day.
Schneider Electric S.E. (SBGSY) Analyst/Investor Day Transcript
Schneider Electric S.E. (SBGSY) Analyst/Investor Day Transcript
Synopsys Sees Bullish Shift as Ansys Integration Drives Growth
Synopsys NASDAQ: SNPS has turned the corner after a year of uncertainty. The company's guidance for Q4 fiscal year 2026 (FY2026) reveals accelerating integration of its services and stabilization of the business.
Gold may be volatile next week, but analysts recommend buying the dip
Neils Christensen has a diploma in journalism from Lethbridge College and has more than a decade of reporting experience working for news organizations throughout Canada. His experiences include covering territorial and federal politics in Nunavut, Canada.
Treasury Yields Snapshot: December 12, 2025
The yield on the 10-year note finished December 12, 2025 at 4.19%. Meanwhile, the 2-year note ended at 3.52% and the 30-year note ended at 4.85%.
Wall Street bereft of gold bears after Fed cuts and T-bill purchases, Main Street leans more bullish as price holds near $4,300/oz
Ernest Hoffman is a Crypto and Market Reporter for Kitco News. He has over 15 years of experience as a writer, editor, broadcaster and producer for media, educational and cultural organizations.
My Tune Is Changing On Apple In 2026: Here's Why
Among all the mega-cap tech stocks in the U.S. market I've largely ignored for most of the past year, Apple (NASDAQ:AAPL) is the first company that comes to mind.
Watsco, Inc. (WSO) Analyst/Investor Day Transcript
Watsco, Inc. (WSO) Analyst/Investor Day Transcript
IMTM: Signs Of Growth Rebound Support Momentum Factor
iShares MSCI Intl Momentum Factor ETF (IMTM) offers ex-US momentum exposure but closely tracks broader international indices like IXUS. IMTM is overweight financials and industrials, making it highly sensitive to macroeconomic trends in countries like Japan, Canada, and Europe. Recent US growth prospects and rate decisions provide a near-term rally force for global markets, yet USD hedge value has diminished and sectoral differentiation is minor.
ProPetro enters power supply agreement with Coterra's unit
Oilfield services provider ProPetro Holding Corp announced on Friday that its energy unit, PROPWR, signed a deal with a unit of Coterra Energy to supply power for building and installing microgrids in New Mexico's Permian Basin.
Nu Holdings: A Top Fintech Pick For 2026
Nu Holdings demonstrates strong growth momentum, adding over 17M new customers in Q3. Revenues soared 42% year-over-year. The Fintech has a superior growth profile and a low valuation relative to other Fintechs, making it an attractive long-term revaluation play. NU is seeing improving monetization in its core market, Brazil. The Fintech is set to go on the offensive in 2026 by pursuing a bank license.
A Bad Week for Oracle Stock Got Even Worse on Friday. Here's Why
A bad week for software maker Oracle (ORCL) ended on a sour note.
Legacy Housing Corporation: Future Growth Prospects Are Compelling
Legacy Housing Corporation remains a "Buy" despite recent revenue and profit declines, supported by a strong balance sheet and attractive valuation. LEGH's Q3 results showed unit sales dropping from 475 to 420, but average revenue per unit rose to $68,500, reflecting pricing power amid industry headwinds. Growth prospects are underpinned by recent acquisitions (AmeriCasa, FutureHomeX, Houston lot), expected to boost retail unit sales by 50%–60% next year.
Oracle may underperform compared to other large cap AI stocks in 2026, says Deepwater's Gene Munster
Gene Munster, Deepwater Asset Mgmt. Managing Partner, joins 'Fast Money' to talk Oracle shares slidding as the air comes out of the AI trade.
'Fast Money' traders talk report Oracle is delaying data centers
The 'Fast Money' traders talk report Oracle is delaying data centers.
Sensata Technologies: Improvements, Albeit Very Modest
Sensata Technologies shows modest organic growth and gradual deleveraging but remains hampered by flattish sales and highly adjusted earnings. Recent SKU rationalization is hurting top-line sales but could improve margins, though tangible benefits remain to be seen. Leverage is trending down, with net debt reduced to $2.43 billion and a 2.9x EBITDA ratio, yet it remains elevated.
MustGrow Biologics sees strong potato yield gains – ICYMI
MustGrow Biologics Corp. (TSX-V:MGRO, OTCQB:MGROF) earlier this week reported positive field trial results for its biofertility product TerraSante, following large-scale testing in US potato crops. COO Colin Bletsky told Proactive about how farmers have started discussing the product's performance within their local networks.
The Best Holiday Present You Can Give Yourself? Costco Stock
Costco NASDAQ: COST is a fantastic buy-and-hold stock for 2026, sustaining industry-leading growth and solid margins despite macroeconomic headwinds and shifting consumer habits. It's also a great last-minute addition to 2026 portfolios, as it trades near a strong support target in mid-December, which limits the downside risks while catalysts are at hand.
BridgeBio Oncology Therapeutics: Promising KRAS Drug Developer - In My View, At Least
BridgeBio Oncology Therapeutics (BBOT) targets KRAS and PI3Ka malignancies with next-generation small molecule therapeutics, aiming to surpass current market leaders. BBOT's lead candidate, BBO-8520, demonstrated a strong overall response rate in early Phase 1a data for KRAS G12C NSCLC, with no Grade 2+ adverse events. All three BBOT pipeline candidates are expected to report Phase 1 data in 2026, positioning the company for key clinical catalysts.
The Score: Warner Bros., GameStop, Campbell's, Lululemon and More Stocks That Defined the Week
Here are some of the major companies whose stocks moved on the week's news.
Tilray's stock takes off on hope that cannabis will soon be treated more like steroids than heroin
Tilray's stock, and shares of other cannabis companies, soared after reports provided investors hope that President Trump would move to have marijuana reclassified as a much less dangerous drug than it is now.
Iron Mountain: Business Issues And High Valuation Make Me Wary (Downgrade)
Iron Mountain Incorporated has shifted toward data centers and digital solutions, driving double-digit revenue growth but not translating into sustainable free cash flow. IRM's aggressive use of non-GAAP metrics and rising leverage—actual net debt/EBITDA near 7.8x—raises material concerns about transparency and financial health. Despite a 10% dividend hike and a 4% yield, IRM's cash burn and high debt levels threaten long-term sustainability and credit quality.
BillionToOne, Inc. (BLLN) Q3 2025 Earnings Call Transcript
BillionToOne, Inc. ( BLLN ) Q3 2025 Earnings Call December 9, 2025 4:30 PM EST Company Participants David Deichler Oguzhan Atay - Co-Founder, Chairman & CEO Ross Taylor - Chief Financial Officer Conference Call Participants Mark Massaro - BTIG, LLC, Research Division Andrew Brackmann - William Blair & Company L.L.C., Research Division David Westenberg - Piper Sandler & Co., Research Division Casey Woodring - JPMorgan Chase & Co, Research Division Brandon Couillard - Wells Fargo Securities, LLC, Research Division Tycho Peterson - Jefferies LLC, Research Division Presentation Operator BillionToOne Third Quarter 2025 Earnings Call.
UnitedHealth: A Long-Term Compounder Worth Holding Through Any Cycle
UnitedHealth remains a "Buy" with a $400 price target, reflecting 19% upside and continued market outperformance potential. UNH delivered a Q3 2025 double-beat, posting 12% revenue growth and exceeding both top- and bottom-line estimates. Despite strong results, the stock experienced a post-earnings pullback, likely due to profit-taking after a 44% rally since August.
California-based startup Copper creates battery-run stoves
CNBC's Diana Olick reports on California-based startup, Copper, who created a battery-powered induction stove as an alternative to more complicated installations.
